In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
57 News Items found
Dr. Wungki Park is seen smiling in a lab.
New Hope for Pancreatic Cancer With Targeted KRAS Drug

A new drug is showing very encouraging results against pancreatic cancer, thanks to clinical trials of daraxonrasib at MSK and other hospitals.
An MSK patient gets a vaccination from a healthcare provider
What To Know About the RSV Vaccines: Who Can Get Them, Side Effects, and Availability at MSK

RSV is a respiratory disease that spreads in the fall and winter months. Learn about the RSV vaccines. People ages 18 to 74 who are at risk for getting very sick from RSV should get vaccinated. Everyone ages 75 and older should get an RSV vaccine.
Researchers Roisin O'Cearbhaill and Christopher Klebanoff
In the Clinic
T Cell Therapies Offer a New Way to Treat Gynecologic Cancers

MSK is a leader in developing new types of immunotherapy for gynecologic cancers, including tumors of the cervix, ovaries, and uterus.
Doctor in green surgical scrubs wearing glasses and cap looking at camera.
Q&A
Q & A: MSK Leads the Way in Treating Head and Neck Cancers

Learn how MSK specialists treat head and neck cancers using the most innovative approaches.
an illustration of a cigarette burning and smoke entering lungs
Feature
How Do Cigarettes Cause Cancer?

Everyone knows that cigarettes cause cancer. But what do we know about how they do it?
Dr. Jun Mao with patient
ASCO 2020: Using Acupuncture to Treat Pain in Cancer Survivors

During the upcoming ASCO Virtual Scientific Program, MSK Chief of Integrative Medicine, Jun J. Mao, MD, MSCE will be presenting a new study comparing the effectiveness of electro-acupuncture (EA) and auricular acupuncture (AA) versus usual care (UC) for chronic musculoskeletal pain in cancer survivors.
Dr. Alexander Drilon speaks with a patient in an exam room
FDA Grants Full Approval to Targeted Therapy for Any Cancer With RET Gene Fusion

Selpercatinib has received full FDA approval for treating tumors anywhere in the body that harbor a genetic change called a RET fusion.
Christina and Kevin walk down stairs. Christina is wearing a blue dress and carrying a bouquet. Kevin is wearing a tuxedo.
FDA Approves New Treatment for Triple-Negative Breast Cancer

The FDA has approved the targeted therapy datopotamab deruxtecan (Datroway® or Dato-DXd) for triple-negative breast cancer based on clinical research led by MSK.
Man in the process of blowing glass at end of a long tube.
Article
How a New Tongue Cancer Treatment Helped an Artist Keep His Voice and His Craft

Learn about a new treatment approach for tongue cancer that allowed a glassblower to continue practicing his art and to find joy in it.
Woman smiling with Central Park in the background.
Article
New Drug Combination Improves Survival for ER+, HER2- Breast Cancer

Learn about a three-drug treatment that has been shown to extend survival for ER+, HER2- breast cancers.